𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Chemotherapy for Advanced Transitional Cell Carcinoma of the Urothelium: Cisplatin or Carboplatin?

✍ Scribed by Stéphane Culine

Book ID
113609793
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
68 KB
Volume
52
Category
Article
ISSN
0302-2838

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Systemic chemotherapy of transitional ce
Systemic chemotherapy of transitional cell carcinoma of the urothelium
✍ William M. Brinkley; Frank M. Torti 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB 👁 3 views

Although the incidence of bladder cancer has increased in recent years, survival has also improved. Chemotherapy has made a substantial impact on this disease and now is used in patients with advanced or metastatic disease as well as in select patients with high-risk muscle invasive disease. While c

A carboplatin-based regimen for the trea
A carboplatin-based regimen for the treatment of patients with advanced transitional cell carcinoma of the urothelium
✍ Eric J. Small; Linda J. Fippin; Mary Lou Ernest; Peter R. Carroll 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

## EIACKGROUND. Many patients with advanced transitional cell carcinoma are unable to receive cisplatin-based therapy. The efficacy and toxicity of a carboplatin-based regimen in the treatment of patients with advanced transitional cell carcinoma was therefore evaluated. ## METHODS. Twenty-thre

Chemotherapy of advanced transitional ce
Chemotherapy of advanced transitional cell carcinoma of the uroepithelium
✍ Frank M. Torti; W. Graydon Harker 📂 Article 📅 1983 🏛 Springer 🌐 English ⚖ 390 KB

Activity has been demonstrated for both single agents and combination chemotherapy in advanced transitional cell carcinoma of the uroepithelium. Regimens are palliative; duration of response has been modest, usually ranging from 3 to 8 months. There are few complete responders; occasional patients r